X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Fresenius Kabi Onco. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs FRESENIUS KABI ONCO. - Comparison Results

FRESENIUS KABI ONCO. 
   Change

Fresenius Kabi Oncology is the erstwhile Dabur Pharma, which was incorporated in March 2003. The company is a leading player in oncology in India and the international markets. Fresenius Kabi Oncology operates in the regulated markets namely the US a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE FRESENIUS KABI ONCO. TTK HEALTHCARE/
FRESENIUS KABI ONCO.
 
P/E (TTM) x 16.7 22.1 75.6% View Chart
P/BV x 5.4 3.1 174.9% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 TTK HEALTHCARE   FRESENIUS KABI ONCO.
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
FRESENIUS KABI ONCO.
Mar-13
TTK HEALTHCARE/
FRESENIUS KABI ONCO.
5-Yr Chart
Click to enlarge
High Rs663176 376.9%   
Low Rs39979 508.3%   
Sales per share (Unadj.) Rs535.637.7 1,421.3%  
Earnings per share (Unadj.) Rs15.95.1 313.1%  
Cash flow per share (Unadj.) Rs20.06.7 297.9%  
Dividends per share (Unadj.) Rs4.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs137.642.5 323.5%  
Shares outstanding (eoy) m7.77158.23 4.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.03.4 29.4%   
Avg P/E ratio x33.325.0 133.3%  
P/CF ratio (eoy) x26.518.9 140.1%  
Price / Book Value ratio x3.93.0 129.1%  
Dividend payout %25.10-   
Avg Mkt Cap Rs m4,12720,135 20.5%   
No. of employees `0001.71.2 148.3%   
Total wages/salary Rs m607703 86.3%   
Avg. sales/employee Rs Th2,436.75,176.2 47.1%   
Avg. wages/employee Rs Th355.2610.4 58.2%   
Avg. net profit/employee Rs Th72.5699.6 10.4%   
INCOME DATA
Net Sales Rs m4,1625,963 69.8%  
Other income Rs m6118 340.0%   
Total revenues Rs m4,2235,981 70.6%   
Gross profit Rs m1971,430 13.8%  
Depreciation Rs m32258 12.3%   
Interest Rs m30-26 -115.0%   
Profit before tax Rs m1971,216 16.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-68 0.0%   
Tax Rs m73342 21.3%   
Profit after tax Rs m124806 15.4%  
Gross profit margin %4.724.0 19.7%  
Effective tax rate %37.028.1 131.5%   
Net profit margin %3.013.5 22.0%  
BALANCE SHEET DATA
Current assets Rs m1,6295,102 31.9%   
Current liabilities Rs m1,0582,385 44.3%   
Net working cap to sales %13.745.6 30.1%  
Current ratio x1.52.1 72.0%  
Inventory Days Days30150 19.8%  
Debtors Days Days34113 29.6%  
Net fixed assets Rs m5565,148 10.8%   
Share capital Rs m78158 49.1%   
"Free" reserves Rs m8786,556 13.4%   
Net worth Rs m1,0696,732 15.9%   
Long term debt Rs m159952 16.7%   
Total assets Rs m2,39910,388 23.1%  
Interest coverage x7.6-45.8 -16.6%   
Debt to equity ratio x0.10.1 104.9%  
Sales to assets ratio x1.70.6 302.2%   
Return on assets %6.47.5 85.4%  
Return on equity %11.612.0 96.8%  
Return on capital %18.514.6 126.4%  
Exports to sales %0.874.5 1.1%   
Imports to sales %1.424.8 5.7%   
Exports (fob) Rs m334,441 0.7%   
Imports (cif) Rs m581,477 3.9%   
Fx inflow Rs m335,298 0.6%   
Fx outflow Rs m631,772 3.6%   
Net fx Rs m-303,525 -0.9%   
CASH FLOW
From Operations Rs m1271,274 9.9%  
From Investments Rs m-146-1,204 12.1%  
From Financial Activity Rs m22-196 -11.2%  
Net Cashflow Rs m3-126 -2.0%  

Share Holding

Indian Promoters % 65.4 0.0 -  
Foreign collaborators % 0.0 81.0 -  
Indian inst/Mut Fund % 3.7 0.3 1,233.3%  
FIIs % 5.2 9.6 54.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 9.1 283.5%  
Shareholders   12,723 42,599 29.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   CADILA HEALTHCARE  J.B.CHEMICALS  ORCHID PHARMA LTD  BIOCON LTD  FULFORD INDIA  

Compare TTK HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 190 Points Higher; Consumer Durable and Healthcare Stocks Witness Buying(Closing)

After trimming sharp losses in the afternoon session, Indian share markets continued to witness buying interest and ended the day on a positive note.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 15.3% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, TTK HEALTHCARE has posted a net profit of Rs 67 m (down 15.3% YoY). Sales on the other hand came in at Rs 2 bn (up 16.3% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY19); Net Profit Down 276.0% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, TTK HEALTHCARE has posted a net profit of Rs 79 m (down 276.0% YoY). Sales on the other hand came in at Rs 2 bn (up 38.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My Top 7 Stocks to Buy Now(The 5 Minute Wrapup)

Nov 30, 2018

Of all the stocks that you could buy in this market, I've picked the seven best safe stocks that offer the ideal combination of safety and profit.

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

Reliance CPSE ETF (FFO3): Should You Invest?(Outside View)

Nov 29, 2018

Personalfn's analysis note on Reliance Mutual Fund Central Public Sector Enterprises Exchange Traded Fund (CPSE ETF). Should you subscribe?

Safety Beats Growth in 2018(Chart Of The Day)

Nov 30, 2018

With the markets turning up, these are my top 7 stock picks.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Dec 11, 2018 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - DR. DATSONS LABS COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS